The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR : What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector? / Minssen, Timo; Seitz, Claudia; Aboy, Mateo; Corrales Compagnucci, Marcelo.

I: European Pharmaceutical Law Review, Bind 4, Nr. 1, 25.03.2020, s. 34 - 50.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Minssen, T, Seitz, C, Aboy, M & Corrales Compagnucci, M 2020, 'The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?', European Pharmaceutical Law Review, bind 4, nr. 1, s. 34 - 50. https://doi.org/10.21552/eplr/2020/1/6

APA

Minssen, T., Seitz, C., Aboy, M., & Corrales Compagnucci, M. (2020). The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector? European Pharmaceutical Law Review, 4(1), 34 - 50. https://doi.org/10.21552/eplr/2020/1/6

Vancouver

Minssen T, Seitz C, Aboy M, Corrales Compagnucci M. The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector? European Pharmaceutical Law Review. 2020 mar 25;4(1):34 - 50. https://doi.org/10.21552/eplr/2020/1/6

Author

Minssen, Timo ; Seitz, Claudia ; Aboy, Mateo ; Corrales Compagnucci, Marcelo. / The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR : What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?. I: European Pharmaceutical Law Review. 2020 ; Bind 4, Nr. 1. s. 34 - 50.

Bibtex

@article{31fa5de2e07240189afacc251d388664,
title = "The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?",
abstract = "Cloud-based technologies, big data, statistical signal processing algorithms, and Artificial Intelligence (AI) technologies are expected to play an increasingly important role in themedical field. Big data and AI-technologies rely on the cloud for data storage as well as for computational power and thus need effective and robust legal frameworks for international data transfer. Because of inconsistent data protection regulations, this is not always simple to achieve as it can be illustrated in the United States (US)–European Union (EU) context. Due to the lack of general data protection law at the federal level, the US currently does not have a general {\textquoteleft}adequacy decision{\textquoteright} from the European Commission (EC) to enable EU-US cross-border data transfers without the need for additional data protection safeguards under GDPR. As a fallback, a {\textquoteleft}limited adequacy{\textquoteright} decision was adopted in 2016 on the so-called {\textquoteleft}EU/US Privacy Shield Framework{\textquoteright}. This framework protects the fundamental rights of natural persons in the EU and allows the free transfer of personal data to companies that are certified under the EU-US Privacy Shield. However, the EU-US Privacy Shield has been recently contested at the Court of Justice of the European Union (CJEU). This paper analyzes the EU-US Privacy Shield Framework, the associated legal challenges, and how these might affect organizations deploying or implementing cloud-based medical technologies relying on cross-border data transfers from EU data subjects. ",
author = "Timo Minssen and Claudia Seitz and Mateo Aboy and {Corrales Compagnucci}, Marcelo",
year = "2020",
month = mar,
day = "25",
doi = "10.21552/eplr/2020/1/6",
language = "English",
volume = "4",
pages = "34 -- 50",
journal = "European Pharmaceutical Law Review",
issn = "2511-7157",
publisher = "Lexxion",
number = "1",

}

RIS

TY - JOUR

T1 - The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR

T2 - What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?

AU - Minssen, Timo

AU - Seitz, Claudia

AU - Aboy, Mateo

AU - Corrales Compagnucci, Marcelo

PY - 2020/3/25

Y1 - 2020/3/25

N2 - Cloud-based technologies, big data, statistical signal processing algorithms, and Artificial Intelligence (AI) technologies are expected to play an increasingly important role in themedical field. Big data and AI-technologies rely on the cloud for data storage as well as for computational power and thus need effective and robust legal frameworks for international data transfer. Because of inconsistent data protection regulations, this is not always simple to achieve as it can be illustrated in the United States (US)–European Union (EU) context. Due to the lack of general data protection law at the federal level, the US currently does not have a general ‘adequacy decision’ from the European Commission (EC) to enable EU-US cross-border data transfers without the need for additional data protection safeguards under GDPR. As a fallback, a ‘limited adequacy’ decision was adopted in 2016 on the so-called ‘EU/US Privacy Shield Framework’. This framework protects the fundamental rights of natural persons in the EU and allows the free transfer of personal data to companies that are certified under the EU-US Privacy Shield. However, the EU-US Privacy Shield has been recently contested at the Court of Justice of the European Union (CJEU). This paper analyzes the EU-US Privacy Shield Framework, the associated legal challenges, and how these might affect organizations deploying or implementing cloud-based medical technologies relying on cross-border data transfers from EU data subjects.

AB - Cloud-based technologies, big data, statistical signal processing algorithms, and Artificial Intelligence (AI) technologies are expected to play an increasingly important role in themedical field. Big data and AI-technologies rely on the cloud for data storage as well as for computational power and thus need effective and robust legal frameworks for international data transfer. Because of inconsistent data protection regulations, this is not always simple to achieve as it can be illustrated in the United States (US)–European Union (EU) context. Due to the lack of general data protection law at the federal level, the US currently does not have a general ‘adequacy decision’ from the European Commission (EC) to enable EU-US cross-border data transfers without the need for additional data protection safeguards under GDPR. As a fallback, a ‘limited adequacy’ decision was adopted in 2016 on the so-called ‘EU/US Privacy Shield Framework’. This framework protects the fundamental rights of natural persons in the EU and allows the free transfer of personal data to companies that are certified under the EU-US Privacy Shield. However, the EU-US Privacy Shield has been recently contested at the Court of Justice of the European Union (CJEU). This paper analyzes the EU-US Privacy Shield Framework, the associated legal challenges, and how these might affect organizations deploying or implementing cloud-based medical technologies relying on cross-border data transfers from EU data subjects.

U2 - 10.21552/eplr/2020/1/6

DO - 10.21552/eplr/2020/1/6

M3 - Journal article

VL - 4

SP - 34

EP - 50

JO - European Pharmaceutical Law Review

JF - European Pharmaceutical Law Review

SN - 2511-7157

IS - 1

ER -

ID: 230518025